Literature DB >> 11689138

Reservoirs for HIV infection and their persistence in the face of undetectable viral load.

S Sonza1, S M Crowe.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11689138     DOI： 10.1089/108729101753205676

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


× No keyword cloud information.
  6 in total

1.  Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.

Authors:  Secondo Sonza; Helen P Mutimer; Kate O'Brien; Philip Ellery; Jane L Howard; Jonathan H Axelrod; Nicholas J Deacon; Suzanne M Crowe; Damian F J Purcell
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy.

Authors:  Janice E Clements; Ming Li; Lucio Gama; Brandon Bullock; Lucy M Carruth; Joseph L Mankowski; M Christine Zink
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

3.  Rational design of drugs that induce human immunodeficiency virus replication.

Authors:  Dean H Hamer; Sven Bocklandt; Louise McHugh; Tae-Wook Chun; Peter M Blumberg; Dina M Sigano; Victor E Marquez
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations.

Authors:  Tushar K Vyas; Aliasgar Shahiwala; Mansoor M Amiji
Journal:  Int J Pharm       Date:  2007-06-19       Impact factor: 5.875

Review 5.  Nanotechnology and the treatment of HIV infection.

Authors:  Raveen Parboosing; Glenn E M Maguire; Patrick Govender; Hendrik G Kruger
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

Review 6.  New hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapy.

Authors:  Jimma Likisa Lenjisa; Minyahil Alebachew Woldu; Gizaw Dabessa Satessa
Journal:  J Nanobiotechnology       Date:  2014-03-22       Impact factor: 10.435
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.